| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I/II study
|
Glinski, Krzysztof
|
|
|
148 |
C |
p. 174-180
|
artikel
|
| 2 |
Advances in cancer imaging require renewed radiotherapy dose and target volume concepts
|
Kaanders, Johannes H.A.M.
|
|
|
148 |
C |
p. 140-142
|
artikel
|
| 3 |
An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective
|
Rim, Chai Hong
|
|
|
148 |
C |
p. 73-81
|
artikel
|
| 4 |
A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises
|
Janssens, Geert O.
|
|
|
148 |
C |
p. 216-222
|
artikel
|
| 5 |
A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy
|
Quirk, Sarah
|
|
|
148 |
C |
p. 167-173
|
artikel
|
| 6 |
Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer
|
Fiandra, Christian
|
|
|
148 |
C |
p. 126-132
|
artikel
|
| 7 |
Breakthrough of COVID-19 using radiotherapy treatment modalities
|
Venkatraman, P.
|
|
|
148 |
C |
p. 225-226
|
artikel
|
| 8 |
Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours
|
Haldbo-Classen, Lene
|
|
|
148 |
C |
p. 1-7
|
artikel
|
| 9 |
Contents
|
|
|
|
148 |
C |
p. v-vii
|
artikel
|
| 10 |
Corrigendum to “Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis” [Radiother Oncol 141 (2019) 56–61]
|
Chow, Ronald
|
|
|
148 |
C |
p. 115
|
artikel
|
| 11 |
COVID-19 and gynecological cancers: A Moroccan point-of-view
|
Ismaili, Nabil
|
|
|
148 |
C |
p. 227-228
|
artikel
|
| 12 |
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases
|
Ippolito, Edy
|
|
|
148 |
C |
p. 201-202
|
artikel
|
| 13 |
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity
|
Saksø, Mette
|
|
|
148 |
C |
p. 65-72
|
artikel
|
| 14 |
4D CT image artifacts affect local control in SBRT of lung and liver metastases
|
Sentker, Thilo
|
|
|
148 |
C |
p. 229-234
|
artikel
|
| 15 |
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|
Lievens, Yolande
|
|
|
148 |
C |
p. 157-166
|
artikel
|
| 16 |
Development of transient radioresistance during fractionated irradiation in vitro
|
van den Berg, Jaap
|
|
|
148 |
C |
p. 107-114
|
artikel
|
| 17 |
Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening
|
Li, Zhihao
|
|
|
148 |
C |
p. 21-29
|
artikel
|
| 18 |
Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose–volume histogram using ensemble machine learning
|
Pan, Xiaoying
|
|
|
148 |
C |
p. 181-188
|
artikel
|
| 19 |
Editorial Board
|
|
|
|
148 |
C |
p. ii
|
artikel
|
| 20 |
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer
|
Calvo, Felipe A.
|
|
|
148 |
C |
p. 57-64
|
artikel
|
| 21 |
Evolution of clinical radiotherapy physics practice under COVID-19 constraints
|
Khan, Rao
|
|
|
148 |
C |
p. 274-278
|
artikel
|
| 22 |
Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer
|
Oud, Michelle
|
|
|
148 |
C |
p. 143-150
|
artikel
|
| 23 |
FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status
|
Urban, Ryan
|
|
|
148 |
C |
p. 14-20
|
artikel
|
| 24 |
GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy
|
Siebert, Frank-André
|
|
|
148 |
C |
p. 51-56
|
artikel
|
| 25 |
Implications for cancer care in Iran during COVID-19 pandemic
|
Akbarzadeh, Mohammad Amin
|
|
|
148 |
C |
p. 211-212
|
artikel
|
| 26 |
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
|
Marijnen, C.A.M.
|
|
|
148 |
C |
p. 213-215
|
artikel
|
| 27 |
Investigation of the evolution of radiation-induced lung damage using serial CT imaging and pulmonary function tests
|
Veiga, Catarina
|
|
|
148 |
C |
p. 89-96
|
artikel
|
| 28 |
Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy
|
Van den Bosch, Lisa
|
|
|
148 |
C |
p. 151-156
|
artikel
|
| 29 |
Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy
|
Zhou, Suizi
|
|
|
148 |
C |
p. 116-125
|
artikel
|
| 30 |
Managing a radiotherapy center safely and efficiently using risk-adaptive strategies during coronavirus disease pandemic: Experience from national cancer center of China
|
Bi, Nan
|
|
|
148 |
C |
p. 243-244
|
artikel
|
| 31 |
Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19
|
Ning, Matthew S.
|
|
|
148 |
C |
p. 252-257
|
artikel
|
| 32 |
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore
|
Tey, Jeremy
|
|
|
148 |
C |
p. 189-193
|
artikel
|
| 33 |
Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose
|
Reijtenbagh, Dominique M.W.
|
|
|
148 |
C |
p. 38-43
|
artikel
|
| 34 |
Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy
|
Pasalic, Dario
|
|
|
148 |
C |
p. 258-266
|
artikel
|
| 35 |
Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy
|
Wentzel, Andrew
|
|
|
148 |
C |
p. 245-251
|
artikel
|
| 36 |
Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics
|
Wilkie, Joel R.
|
|
|
148 |
C |
p. 30-37
|
artikel
|
| 37 |
Predicting poor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Model constructed using pre-treatment MRI features of structured report template
|
Tang, Xiaofeng
|
|
|
148 |
C |
p. 97-106
|
artikel
|
| 38 |
Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer
|
Grant, Stephen R.
|
|
|
148 |
C |
p. 133-139
|
artikel
|
| 39 |
Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy
|
Yoon, Stephanie
|
|
|
148 |
C |
p. 44-50
|
artikel
|
| 40 |
Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial
|
Nestle, Ursula
|
|
|
148 |
C |
p. 82-88
|
artikel
|
| 41 |
Radiotherapy imaging: An unexpected ally in fighting COVID 19 pandemic
|
Boldrini, Luca
|
|
|
148 |
C |
p. 223-224
|
artikel
|
| 42 |
Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China
|
Wei, Wei
|
|
|
148 |
C |
p. 203-210
|
artikel
|
| 43 |
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19
|
Tchelebi, Leila T.
|
|
|
148 |
C |
p. 194-200
|
artikel
|
| 44 |
Role of T0 status in overall survival for unresectable stage III non-small cell lung cancer: A NCDB analysis
|
Komiya, Takefumi
|
|
|
148 |
C |
p. 8-13
|
artikel
|
| 45 |
Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic
|
Mendez, Lucas C.
|
|
|
148 |
C |
p. 270-273
|
artikel
|
| 46 |
Spanish risk management framework across 17 radiation oncology centers during COVID-19 pandemic
|
Suárez-Gironzini, Vladimir
|
|
|
148 |
C |
p. 267-269
|
artikel
|
| 47 |
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials
|
Lehrer, Eric J.
|
|
|
148 |
C |
p. 235-242
|
artikel
|
Tijdschrift beschrijving